Pharmacogenomics for cancers with compromised p53 by mdm2 SNP309 or mutations in the p53 gene

被引：0
|
作者：
Polotskaia, Alla
Brekman, Angelika
Gamms, Sandy
Melendez, Alicia
Bargonetti, Jill
机构：
[1] CUNY Hunter Coll, New York, NY 10021 USA
[2] CUNY, Grad Ctr, New York, NY USA
[3] CUNY Queens Coll, New York, NY USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2906
引用
收藏
页数：1
相关论文
共 50 条
  • [1] MDM2 SNP 309 and p53 mutations in metastatic malignant melanoma
    Busch, Christian
    Geisler, Jurgen
    Lillehaug, Johan
    Lonning, Per
    CANCER RESEARCH, 2008, 68 (09)
  • [2] Association of breast cancer outcome with status of p53 and MDM2 SNP309
    Boersma, Brenda J.
    Howe, Tiffany M.
    Goodman, Julie E.
    Yfantis, Harry G.
    Lee, Dong H.
    Chanock, Stephen J.
    Ambs, Stefan
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (13) : 911 - 919
  • [3] Prediction of Breast Cancer Outcome by p53 Depends on MDM2 SNP309
    Boersma, Brenda J.
    Howe, Tiffany
    Goodman, Julie
    Yfantis, Harry
    Prueitt, Robyn
    Lee, Dong
    Chanock, Stephen
    Ambs, Stefan
    CANCER RESEARCH, 2006, 66 (08)
  • [4] Cancer cells with G/G mdm2 SNP309 have compromised transcriptional elongation of p53 target genes
    Rosso, Melissa
    Polotskaia, Alla
    Bargonetti, Jill
    CANCER RESEARCH, 2014, 74 (19)
  • [5] Association of p53 Arg72Pro and MDM2 SNP309 polymorphisms with glioma
    Zhang, J. N.
    Yi, S. H.
    Zhang, X. H.
    Liu, X. Y.
    Mao, Q.
    Li, S. Q.
    Xiong, W. H.
    Qiu, Y. M.
    Chen, T.
    Ge, J. W.
    GENETICS AND MOLECULAR RESEARCH, 2012, 11 (04) : 3618 - 3628
  • [6] Gene Polymorphisms Of P53 At Codon 72 And Mdm2 Snp309 Are Associated With Emphysematous Changes In COPD Patients
    Mizuno, S.
    Ishizaki, T.
    Kadowaki, M.
    Gomez-Arroyo, J. G.
    Kraskauskas, D.
    Voelkel, N. F.
    Osanai, K.
    Toga, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [7] MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1
    Olsson, Hans
    Hultman, Per
    Rosell, Johan
    Soderkvist, Peter
    Jahnson, Staffan
    BMC UROLOGY, 2013, 13
  • [8] MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1
    Hans Olsson
    Per Hultman
    Johan Rosell
    Peter Söderkvist
    Staffan Jahnson
    BMC Urology, 13
  • [9] MDM2 SNP309 and p53 Codon 72 Genetic Polymorphisms and Risk of AML: an Egyptian Study
    El-Danasouri, Nabil Mohsen
    Ragab, Shadia Hassan
    Rasheed, Maha Ameen
    El Saadany, Zainab Ali
    Abd El-Fattah, Safa Nabil
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2014, 44 (04): : 449 - 454
  • [10] MDM2 SNP309 modifies the prognostic significance of the p53 mutational status in patients with ovarian cancer
    Hofstetter, Gerda
    Berger, Astrid
    Bauer, Eva-Maria
    Schuster, Eva
    Wolf, Andrea
    Chamson, Martina
    Mueller-Holzner, Elisabeth
    Reimer, Daniel
    Braicu, Elena I.
    Sehouli, Jalid
    Ulmer, Hanno
    Castillo-Tong, Dan Cacsire
    Zeillinger, Robert
    Concin, Nicole
    ONCOLOGY REPORTS, 2012, 27 (03) : 673 - 677
12345